Wednesday, August 12, 2026

HomeHealth NewsHigh-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds

High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds

- Advertisement -

Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAID

A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This severe form of tuberculosis causes inflammation of the brain membranes, and half of the patients die. These findings come from a large international study conducted by Radboud…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed